Drug Type Small molecule drug |
Synonyms Velostan, BPP-03B04, NSC-19048 + [1] |
Target- |
Action scavengers |
Mechanism Reactive oxygen species scavengers |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC30H30O8 |
InChIKeyQBKSWRVVCFFDOT-UHFFFAOYSA-N |
CAS Registry303-45-7 |
Start Date01 Feb 2026 |
Sponsor / Collaborator |
Start Date18 Dec 2019 |
Sponsor / Collaborator |
Start Date01 Sep 2013 |
Sponsor / Collaborator |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Lung Non-Small Cell Carcinoma | Phase 3 | China | 01 Sep 2013 | |
| Breast Cancer | Phase 2 | - | - | |
| Breast Cancer | Phase 2 | - | - | |
| Advanced Malignant Solid Neoplasm | Phase 1 | South Korea | 18 Dec 2019 |
| Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
|---|
No Data | |||||||







